Kenya

in page functions
[French]
Total population (2016) 47,251,289
Birth cohort (2016) 1,586,294
Surviving Infants (surviving to 1 year per year, 2016) 1,508,163
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 36/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 49/1000
World Bank Index, IDA (2012) 3.79
Co-financing status (2016) Preparatory transition
No. of districts/territories (2014) 286

Gavi support for Kenya

Type of support

Approvals

2001-2020 (US$)
(31 Mar 2016)

Commitments

2001-2020 (US$)
(31 Mar 2016)

Disbursements

2000-2016 (US$)
(31 Mar 2016)

% Disbursed

(31 Mar 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Cash Support (CASHSUPP) $348,000 $348,000 $145,000 42%
Health system strengthening (HSS 1) $9,903,000 $9,903,000 $9,903,000 100%
HPV Demo (NVS) $718,749 $718,749 $581,249 81%
Immunisation services support (ISS) $6,420,320 $6,420,320 $4,217,180 66%
Injection safety support (INS) $1,129,963 $1,129,963 $1,129,963 100%
IPV (NVS) $2,743,862 $4,524,362 $2,245,368 82%
Measles-Rubella (NVS) $13,980,455 $13,980,455 $13,513,824 97%
MR - Operational costs (OPC) $12,332,500 $12,332,500 $12,332,500 100%
Penta (NVS) $163,923,544 $170,891,544 $161,892,669 99%
Pneumo (NVS) $175,491,253 $192,661,753 $179,378,629 102%
Rotavirus (NVS) $16,873,182 $23,433,682 $14,883,277 88%
Vaccine Introduction Grant (VIG) $4,282,500 $4,282,500 $4,282,500 100%
Yellow Fever (NVS) $458,910 $3,608,410 $383,715 84%
Total $408,606,238 $444,235,238 $404,888,873

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Kenya DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 81%
M:F sex ratio at birth (2016) 1.03
Household survey: DTP3 coverage for male (2007) 82.90%
Household survey: DTP3 coverage for female (2007) 89.80%
Household survey: Last DTP3 survey (2007) 86%
% districts achieving > 80% DTP3 coverage (2014) 47%
% districts achieving < 50% DTP3 coverage (2014) 10%
MCV WHO/UNICEF estimates (2014) 79%

Breakdown of support

Non-vaccine support Vaccine support
8% 92%
$32,010,142 $372,878,727

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Kenya

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

05 February 2016

Pentavalent vaccine

Study shows near elimination of Hib disease in Kilifi region of Kenya after introduction of vaccine

Welcome Trust and Gavi funded research also shows Hib booster not needed for long-term protection.

17 July 2015

India pentavalent scale-up 2014

New coverage figures show more children than ever being reached with immunisation in poorest countries

Coverage trends heading in right direction but major differences remain between countries.

close icon

modal window here